NasdaqCM - Delayed Quote USD

bioAffinity Technologies, Inc. (BIAFW)

0.1711
+0.0011
+(0.65%)
At close: April 25 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,362.0220
9,362.0220
2,532.4990
4.8030
0
Cost of Revenue
5,983.4750
5,983.4750
1,740.8840
0.4670
0
Gross Profit
3,378.5470
3,378.5470
791.6150
4.3360
0
Operating Expense
12,331.9920
12,331.9920
8,764.8430
4,015.3940
2,206.8220
Operating Income
-8,953.4450
-8,953.4450
-7,973.2280
-4,011.0580
-2,206.8220
Net Non Operating Interest Income Expense
-74.8650
-74.8650
85.0060
-2,485.9320
-1,001.4300
Other Income Expense
0.1290
0.1290
-27.7960
-1,654.6640
-3,116.2110
Pretax Income
-9,028.1810
-9,028.1810
-7,916.0180
-8,151.6540
-6,324.4630
Tax Provision
11.6500
11.6500
20.9930
2.4590
1.9500
Net Income Common Stockholders
-9,039.8310
-9,039.8310
-7,937.0110
-8,154.1130
-6,326.4130
Diluted NI Available to Com Stockholders
-9,039.8310
-9,039.8310
-7,937.0110
-8,154.1130
-6,326.4130
Total Operating Income as Reported
-8,953.4450
-8,953.4450
-7,973.2280
-4,011.0580
-2,206.8220
Total Expenses
18,315.4670
18,315.4670
10,505.7270
4,015.8610
2,206.8220
Net Income from Continuing & Discontinued Operation
-9,039.8310
-9,039.8310
-7,937.0110
-8,154.1130
-6,326.4130
Normalized Income
-9,039.8310
-9,039.8310
-7,937.0110
-8,366.3710
-3,522.3815
Interest Income
17.6100
17.6100
122.1310
46.7080
0.4240
Interest Expense
92.4750
92.4750
37.1250
2,532.6400
1,001.8540
Net Interest Income
-74.8650
-74.8650
85.0060
-2,485.9320
-1,001.4300
EBIT
-8,935.7060
-8,935.7060
-7,878.8930
-5,619.0140
-5,322.6090
EBITDA
-8,330.0690
-8,330.0690
-7,629.3010
-5,608.8320
-5,317.7920
Reconciled Cost of Revenue
5,983.4750
5,983.4750
1,740.8840
0.4670
0
Reconciled Depreciation
605.6370
605.6370
249.5920
10.1820
4.8170
Net Income from Continuing Operation Net Minority Interest
-9,039.8310
-9,039.8310
-7,937.0110
-8,154.1130
-6,326.4130
Total Unusual Items Excluding Goodwill
--
--
0
212.2580
-3,841.1390
Total Unusual Items
--
--
0
212.2580
-3,841.1390
Normalized EBITDA
-8,330.0690
-8,330.0690
-7,629.3010
-5,821.0900
-1,476.6530
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0.0003
Tax Effect of Unusual Items
0
0
0
0
-1,037.1075
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IZOZF Izotropic Corporation
0.1900
+5.56%
 
PRPH ProPhase Labs, Inc.
0.3030
-0.33%
 
NDRA ENDRA Life Sciences Inc.
3.2600
-46.99%
 
VCYT Veracyte, Inc.
29.71
-4.81%
 
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
 
EXAS Exact Sciences Corporation
51.63
-2.70%
 
DHR Danaher Corporation
189.73
-2.61%
 
ILMN Illumina, Inc.
75.76
-4.80%
 
TMO Thermo Fisher Scientific Inc.
403.13
-1.86%